NAD+ is a coenzyme, not a peptide
Cardiovascular Protection GLP-1 receptor agonists are also known to reduce the risk of cardiovascular events, such as heart attacks and strokes, which are prevalent among older adults
Because Melanotan II interacts with more receptor types, it can also affect other body systems, including those related to energy balance and sexual response
Zepbound, for example, is designed for people with overweight (which is considered as a BMI of 27 or above) or obesity (a BMI of 30 or above) who also have one or more weight-related conditions like type 2 diabetes, high blood pressure, or high cholesterol
When the medication is stopped, most patients regain a significant portion of the weight they lost
Regardless, weight loss varies depending on dosage, diet, physical activity, and levels